Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Hospira, Inc.
Radiofrequencies from the incontinence-sensing devices may interfere with other medical equipment in a hospital setting.
Edwards Lifesciences CEO Mike Mussallem has a unique and long-standing perspective of what the medtech industry should be and do. In over two decades, he has built the structural heart disease and critical care monitoring company into one of the global medtech industry’s most effective innovators.
The company reported in October that it was reviewing its portfolio and would offer more details on its future plans in January. Wells Fargo analysts expect Baxter to split its fast-growing connected care business from its lower-margin hospital-based therapeutics products.
While generic drug prices continued to erode in the US during the second quarter of FY23, compliance will be key to the performance of Indian firms such as Torrent and Jubilant through the rest of the year. The US FDA has issued multiple observations in 2022, but an import alert for Glenmark’s Baddi unit is the harshest so far.
- Other Names / Subsidiaries
- Javelin Pharmaceuticals, Inc.
- Mayne Pharma Limited